Category Navigation:

Dorsomorphin | Compound C | CAS# 866405-64-3 | AMPK Inhibitor. Also inhibits BMP type I receptors ALK2, ALK3 and ALK6
Dorsomorphin
Product Number: D-1310

Details

Dorsomorphin, compound C is a cell-permeable pyrrazolopyrimidine derivative that inhibits AMP kinase in an ATP-competitive manner. Dorsomorphin displays no significant inhibition of ZAPK, SYKK, PKCT, PKA and JAK3. Dorsomorphin decreases food intake in mice and inhibits the effects of AICAR and metformin. Dorsomorphin has been shown to inhibit BMP type I receptors ALK2, ALK3 and ALK6.

Bone morphogenetic protein (BMP) are members of the transforming growth factor-β (TGF-β) superfamily determining embryonic patterning and tissue morphogenesis. The recent discovery of dorsomorphin, the first chemical inhibitor of BMP receptor signaling bone disease provides hope for future fibrodysplasia ossificans progressiva (FOP) therapies.

Additional Information

COA Documentation:
Product Number D-1310
CAS # 866405-64-3
Chemical Name 6-[4-(2-Piperidin-1-yl)-ethoxy)- phenyl)]-3-pyridin-4-yl- pyrazolo[1,5-a]-pyrimidine
Chemical Formula C24H25N5O
Alternative Name Compound C, AMPK INHIBITOR
Appearance Light yellow solid
Handling Protect from air&light
Molecular Weight 399.49
Purity >98%
Solubility Soluble in DMSO
Storage Temp -20°C

Dorsomorphin | Compound C | CAS# 866405-64-3 | AMPK Inhibitor. Also inhibits BMP type I receptors ALK2, ALK3 and ALK6

Double click on above image to view full picture

Zoom Out
Zoom In

More Views

  • Dorsomorphin | Compound C | CAS# 866405-64-3 | AMPK Inhibitor. Also inhibits BMP type I receptors ALK2, ALK3 and ALK6
Related Products

Check items to add to the cart or select all